Paraneoplastic Disorders
@article{Lancaster2017ParaneoplasticD, title={Paraneoplastic Disorders}, author={Eric Lancaster}, journal={CONTINUUM: Lifelong Learning in Neurology}, year={2017}, volume={23}, pages={1653–1679} }
ABSTRACT Purpose of Review: Paraneoplastic neurologic syndromes target specific areas of the nervous system with pathogenic autoantibodies or T-cell responses. Each syndrome conveys a risk of particular tumors. Expanded paraneoplastic antibody testing has led to improved diagnosis but created challenges involving appropriate interpretation of test results. Recent Findings: Peripheral nervous system paraneoplastic disorders such as myasthenia gravis and Lambert-Eaton myasthenic syndrome involve…
Figures and Tables from this paper
3 Citations
Paraneoplastic neurological syndromes with onconeural antibodies: A single center retrospective study
- Medicine, BiologyJournal of the Neurological Sciences
- 2020
Paraneoplastic sensorimotor neuropathy and ventral cauda equina nerve root enhancement as initial presentation of small cell lung carcinoma: a case study
- MedicineBMC Neurology
- 2021
Onconeural negative paraneoplastic radiculoneuropathy can precede diagnosis of small cell lung carcinoma and if considered early and adequately investigated, it can allow earlier diagnosis and treatment of underlying malignancy, improving overall and neurological prognosis.
References
SHOWING 1-10 OF 51 REFERENCES
Anti-Ma and anti-Ta associated paraneoplastic neurological syndromes: 22 newly diagnosed patients and review of previous cases
- Medicine, BiologyJournal of Neurology, Neurosurgery, and Psychiatry
- 2008
Refining and expanding the range of anti-Ma/anti-Ta associated neurological presentations and tumours clearly demonstrated that the distinction between anti- Ma and anti- Ta associated PNS is of high clinical relevance.
Amphiphysin autoimmunity: Paraneoplastic accompaniments
- Medicine, BiologyAnnals of neurology
- 2005
Only 10% of women (some with lung carcinoma) and 4% of men fulfilled diagnostic criteria for stiff‐man syndrome, and patients with isolated amphiphysin‐IgG were more likely to be women and to have myelopathy or stiff‐ man phenomena.
Anti‐neuronal nuclear autoantibody type 2: Paraneoplastic accompaniments
- Medicine, BiologyAnnals of neurology
- 2003
We identified the IgG autoantibody ANNA‐2 (“anti‐Ri”) in 34 patients in a 12‐year period by immunofluorescence screening of sera from approximately 75,000 patients with subacute neurological…
Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients.
- MedicineBrain : a journal of neurology
- 2001
The predictors of mortality and PEM evolution found in the study may be important in the design of future therapeutic protocols, and emphasize the importance of early diagnosis and treatment of the underlying tumour.
Onco-neural antibodies and tumour type determine survival and neurological symptoms in paraneoplastic neurological syndromes with Hu or CV2/CRMP5 antibodies
- Medicine, PsychologyJournal of Neurology, Neurosurgery, and Psychiatry
- 2008
It is demonstrated that in patients with paraneoplastic neurological syndromes, the neurological symptoms and survival vary with both the type of associated onco-neural antibody and thetype of tumour.
Clinical analysis of anti-Ma2-associated encephalitis.
- Medicine, PsychologyBrain : a journal of neurology
- 2004
Anti-Ma2 encephalitis (with or without anti-Ma1 antibodies) should be suspected in patients with limbic, diencephalic or brainstem dysfunction, MRI abnormalities in these regions, and inflammatory changes in the CSF.
Antibodies to the GABAB receptor in limbic encephalitis with seizures: case series and characterisation of the antigen
- Medicine, BiologyThe Lancet Neurology
- 2010
Homer 3 autoimmunity in subacute idiopathic cerebellar ataxia
- Medicine, BiologyNeurology
- 2007
The antigen of a new anti-Purkinje cell antibody identified in a patient with idiopathic subacute cerebellar ataxia is characterized and a possible immune-mediated pathogenesis is suggested.
Glutamic acid decarboxylase autoimmunity with brainstem, extrapyramidal, and spinal cord dysfunction.
- Medicine, BiologyMayo Clinic proceedings
- 2006
A patient with a presumed neurodegenerative disorder of new onset, with high levels of GAD65 antibody (>20 nmol/L), merits consideration of immunotherapy.
Paraneoplastic cerebellar degeneration.
- MedicineNeurology
- 1992
The presence of the anti-Yo antibody in patients with cerebellar symptoms warrants an aggressive approach to diagnosis and treatment of the underlying cancer, as many are curable at the time neurologic symptoms develop.